Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grabowska

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Advanced Healthcare Materials|December 8, 2025
Hybrid Scaffolds Decouple Biochemical & Biophysical Regulation of Cell PhenotypeXinyuan Song, Samantha C Mitchell, Abbie N Smart, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and MutationKyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2026
Modular Supramolecular Polycations Enable Efficient Delivery of Diverse RNA Therapeutics and VaccinesRafał Jerzy Kopiasz, Hadijatou J Sallah, Robert J Cavanagh, et al.
Cell Reports. Medicine|June 22, 2022
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblastsBenjamin P Sharpe, Annette Hayden, Antigoni Manousopoulou, et al.
Journal of Medicinal Chemistry|May 21, 2020
Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity <i>in Vivo</i> Mouse ModelChristophe Fromont, Alessio Atzori, Divneet Kaur, et al.
Ecology Letters|February 24, 2022
AVONET: morphological, ecological and geographical data for all birdsJoseph A Tobias, Catherine Sheard, Alex L Pigot, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Advanced Healthcare Materials|December 8, 2025
Hybrid Scaffolds Decouple Biochemical & Biophysical Regulation of Cell PhenotypeXinyuan Song, Samantha C Mitchell, Abbie N Smart, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and MutationKyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2026
Modular Supramolecular Polycations Enable Efficient Delivery of Diverse RNA Therapeutics and VaccinesRafał Jerzy Kopiasz, Hadijatou J Sallah, Robert J Cavanagh, et al.
Cell Reports. Medicine|June 22, 2022
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblastsBenjamin P Sharpe, Annette Hayden, Antigoni Manousopoulou, et al.
Journal of Medicinal Chemistry|May 21, 2020
Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity <i>in Vivo</i> Mouse ModelChristophe Fromont, Alessio Atzori, Divneet Kaur, et al.
Ecology Letters|February 24, 2022
AVONET: morphological, ecological and geographical data for all birdsJoseph A Tobias, Catherine Sheard, Alex L Pigot, et al.
Pageof 19